journal article·2015-03Open access

Prolonged prevention of retinal degeneration with retinylamine loaded nanoparticles

Anthony Puntel, Akiko Maeda, Marcin Golczak, Song-Qi Gao, Guanping Yu, Krzysztof Palczewski, Zheng-Rong Lu

Biomaterials· Volume 44

Abstract

Retinal degeneration impairs the vision of millions in all age groups worldwide. Increasing evidence suggests that the etiology of many retinal degenerative diseases is associated with impairment in biochemical reactions involved in the visual cycle, a metabolic pathway responsible for regeneration of the visual chromophore (11-cis-retinal). Inefficient clearance of toxic retinoid metabolites, especially all-trans-retinal, is considered responsible for photoreceptor cytotoxicity. Primary amines, including retinylamine, are effective in lowing the concentration of all-trans-retinal within the retina and thus prevent retina degeneration in mouse models of human retinopathies. Here we achieved prolonged prevention of retinal degeneration by controlled delivery of retinylamine to the eye from polylactic acid nanoparticles in Abca4(-/-)Rdh8(-/-) (DKO) mice, an animal model of Stargardt disease/age-related macular degeneration. Subcutaneous administration of the nanoparticles containing retinylamine provided a constant supply of the drug to the eye for about a week and resulted in effective prolonged prevention of light-induced retinal degeneration in DKO mice. Retinylamine nanoparticles hold promise for prolonged prophylactic treatment of human retinal degenerative diseases, including Stargardt disease and age-related macular degeneration.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Retinal Development and Disorders · Retinal Diseases and Treatments · Retinoids in leukemia and cellular processes

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (32)

Show source-provided references
1. Kiser PD, Golczak M, Palczewski K. Chemistry of the retinoid (visual) cycle. Chem Rev 114:194–232.10.1021/cr400107q ↗
2. A newly discovered visual cycle necessary for vision during continuous illumination10.1301/00296640260085976 ↗
3. The biochemistry of the visual cycle10.1021/cr960141c ↗
4. Palczewski K. Chemistry and biology of vision. J Biol Chem 287:1612–1619.10.1074/jbc.R111.301150 ↗
5. Retinopathy in mice induced by disrupted all-trans-retinal clearance10.1074/jbc.M804505200 ↗
6. Maeda T, Golczak M, Maeda A. Retinal photodamage mediated by all-trans-retinal. Photochem Photobiol 88:1309–1319.10.1111/j.1751-1097.2012.01143.x ↗
7. Chen Y, Okano K, Maeda T, Chauhan V, Golczak M, Maeda A, et al. Mechanism of all-trans-retinal toxicity with implications for Stargardt disease and age-related macular degeneration. J Biol Chem 287:5059–5069.10.1074/jbc.M111.315432 ↗
8. A2E, a byproduct of the visual cycle10.1016/S0042-6989(03)00475-9 ↗
9. Sparrow JR, Wu Y, Kim CY, Zhou J. Phospholipid meets all-trans-retinal: the making of RPE bisretinoids. J Lipid Res 51:247–261.10.1194/jlr.R000687 ↗
10. Biosynthesis of a major lipofuscin fluorophore in mice and humans with ABCR-mediated retinal and macular degeneration10.1073/pnas.130110497 ↗
11. Murdaugh LS, Wang Z, Del Priore LV, Dillon J, Gaillard ER. Age-related accumulation of 3-nitrotyrosine and nitro-A2E in human Bruch's membrane. Exp Eye Res 90:564–571.10.1016/j.exer.2010.01.014 ↗
12. Primary amines protect against retinal degeneration in mouse models of retinopathies10.1038/nchembio.759 ↗
13. Kubota R, Boman NL, David R, Mallikaarjun S, Patil S, Birch D. Safety and effect on rod function of ACU-4429, a novel small-molecule visual cycle modulator. Retina 32:183–188.10.1097/IAE.0b013e318217369e ↗
14. Metabolic basis of visual cycle inhibition by retinoid and nonretinoid compounds in the vertebrate retina10.1074/jbc.M708982200 ↗
15. Positively charged retinoids are potent and selective inhibitors of the trans-cis isomerization in the retinoid (visual) cycle10.1073/pnas.0503318102 ↗
16. Ophthalmic drug discovery: novel targets and mechanisms for retinal diseases and glaucoma10.1038/nrd3745 ↗
17. Recent perspectives in ocular drug delivery10.1007/s11095-008-9694-0 ↗
18. Nanomedicines for back of the eye drug delivery, gene delivery, and imaging10.1016/j.preteyeres.2013.04.001 ↗
19. Membrane receptors and transporters involved in the function and transport of vitamin A and its derivatives10.1016/j.bbalip.2011.06.010 ↗
20. Multifunctional PEG retinylamine conjugate provides prolonged protection against retinal degeneration in mice10.1021/bm501352s ↗
21. Biodegradable implants for sustained drug release in the eye10.1007/s11095-010-0159-x ↗
22. Repair of Achilles tendon defect with autologous ASCs engineered tendon in a rabbit model10.1016/j.biomaterials.2014.06.058 ↗
23. The effect of hyperbranched polyglycerol coatings on drug delivery using degradable polymer nanoparticles10.1016/j.biomaterials.2014.04.038 ↗
24. Neurogenesis and vascularization of the damaged brain using a lactate-releasing biomimetic scaffold10.1016/j.biomaterials.2014.02.051 ↗
25. Biodegradable polymeric vesicles containing magnetic nanoparticles, quantum dots and anticancer drugs for drug delivery and imaging10.1016/j.biomaterials.2014.01.041 ↗
26. SM5-1-conjugated PLA nanoparticles loaded with 5-fluorouracil for targeted hepatocellular carcinoma imaging and therapy10.1016/j.biomaterials.2013.12.045 ↗
27. The effect of autophagy inhibitors on drug delivery using biodegradable polymer nanoparticles in cancer treatment10.1016/j.biomaterials.2013.10.034 ↗
28. Lecithin:retinol acyltransferase is responsible for amidation of retinylamine, a potent inhibitor of the retinoid cycle10.1074/jbc.M509351200 ↗
29. Influence of particle geometry and PEGylation on phagocytosis of particulate carriers10.1016/j.ijpharm.2014.02.037 ↗
30. Binding of N-retinylidene-PE to ABCA4 and a model for its transport across membranes10.1007/0-387-32442-9_64 ↗
31. Identification and characterization of all-trans-retinol dehydrogenase from photoreceptor outer segments, the visual cycle enzyme that reduces all-trans-retinal to all-trans-retinol10.1074/jbc.275.15.11034 ↗
32. Involvement of all-trans-retinal in acute light-induced retinopathy of mice10.1074/jbc.M900322200 ↗